HEMATOLOGY/ONCOLOGY TEAM (HOT) INTERNSHIP FOR PHARMACY STUDENTS UNC Lineberger Comprehensive Cancer Center | N.C. Cancer Hospital Chapel Hill, NC Application Deadline: February 5, 2018 Link to Application Website: https://learn.pharmacy.unc.edu/internship
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
HEMATOLOGY/ONCOLOGY TEAM (HOT) INTERNSHIP
FOR PHARMACY STUDENTS
UNC Lineberger Comprehensive Cancer Center | N.C. Cancer Hospital
Chapel Hill, NC
Application Deadline: February 5, 2018 Link to Application Website: https://learn.pharmacy.unc.edu/internship
The HOT internship is a two-year paid internship for pharmacy students that begins the summer after the first year of pharmacy school. Interns will gain expo-sure to the fields of hematology and oncology phar-macy through operational, clinical, and research ex-periences.
Structure:
Summer after PY1 Year: 4-5 weeks of technician training in the Cancer Hos-
pital Infusion Pharmacy (CHIP) 4-5 weeks of clinical/administrative rotations with
oncology pharmacists PY2 School Year: Technician staffing in CHIP every third weekend Begin longitudinal research project Summer after PY2 Year: 8-9 weeks of clinical/administrative rotations with
oncology pharmacists Continue longitudinal research project PY3 School Year: Technician staffing in CHIP every third weekend Complete longitudinal research project
After the first summer experience, HOT interns will have the opportunity to collaborate with a hematolo-gy/oncology pharmacy specialist on a longitudinal research project. Types of projects include clinical re-search and quality improvement studies and will last for approximately two academic years. Examples of Current Projects:
Standardization of Preventative Medication Regi-
mens for Chemotherapy-Induced Nausea and
Vomiting in a Pediatric Outpatient Infusion Clinic
(Carolyn Rath, PharmD Candidate c/o 2020)
A Nationwide Study of the Oncology Pharmacist’s
Role in Oral Oncolytic Outcomes (Raena Rhone,
PharmD Candidate c/o 2020)
Past Projects and Publications:
A Comparison of Clofarabine-based (GCLAC) and
Cladribine-based (CLAG) Salvage Chemotherapy
for Relapsed/Refractory AML; Clinical Lympho-
ma, Myeloma & Leukemia, 2017 (Katie
Buhlinger, PharmD c/o 2017)
Retrospective comparison of outcomes in patients
with recurrent or refractory ovarian cancer treat-
ed with PEGylated liposomal doxorubicin at an
academic medical center [Accepted for publica-
tion] (Eric Shen, PharmD c/o 2017)
WHERE ARE THEY NOW? Pharmacy Career Opportunities and Outcomes of